Profound Medical Corp
TSX:PRN

Watchlist Manager
Profound Medical Corp Logo
Profound Medical Corp
TSX:PRN
Watchlist
Price: 10.24 CAD 3.43% Market Closed
Market Cap: 309.1m CAD

Wall Street
Price Targets

PRN Price Targets Summary
Profound Medical Corp

Wall Street analysts forecast PRN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PRN is 15.56 CAD with a low forecast of 15.4 CAD and a high forecast of 16.01 CAD.

Lowest
Price Target
15.4 CAD
50% Upside
Average
Price Target
15.56 CAD
52% Upside
Highest
Price Target
16.01 CAD
56% Upside
Profound Medical Corp Competitors:
Price Targets
CLPT
Clearpoint Neuro Inc
128% Upside
6823
Rion Co Ltd
39% Upside
MDT
Medtronic PLC
12% Upside
603014
Shandong Weigao Blood Purification Products Co Ltd
10% Upside
SN
Smith & Nephew PLC
21% Upside
338220
Vuno Inc
5% Downside
214150
Classys Inc
25% Upside
STMN
Straumann Holding AG
18% Upside

Revenue
Forecast

Revenue Estimate
Profound Medical Corp

The compound annual growth rate of Profound Medical Corp's revenue for the next 3 years is 75%.

N/A
Past Growth
75%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Profound Medical Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Profound Medical Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-37%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PRN's stock price target?
Price Target
15.56 CAD

According to Wall Street analysts, the average 1-year price target for PRN is 15.56 CAD with a low forecast of 15.4 CAD and a high forecast of 16.01 CAD.

What is Profound Medical Corp's Revenue forecast?
Projected CAGR
75%

The compound annual growth rate of Profound Medical Corp's revenue for the next 3 years is 75%.

Back to Top